London, United Kingdom — July 27, 2026 — Vita Hydrokultur Group Ltd (VHK), an innovative biotechnology company pioneering plant-based manufacturing of high-value bioactive ingredients, today announced the opening of its £1.5 million Series A investment round to accelerate commercial expansion and redefine how premium skincare and wellness ingredients are produced. This Release is about Vita Hydrokultur Launches £1.5 Million Series A Funding Round to Transform the Future of Sustainable Skincare Ingredients.
The funding will support the company’s next stage of growth as it scales its proprietary plant molecular farming platform, enabling the production of sustainable, animal-free, pharmaceutical-grade proteins and botanical actives for the global beauty, cosmetics, and life sciences markets.
With consumer demand rapidly shifting toward traceable, ethical, and scientifically validated ingredients, Vita Hydrokultur is positioning itself at the forefront of a new era of precision ingredient manufacturing.
Reinventing the Future of Beauty Through Plant Biotechnology
The global cosmeceutical industry is experiencing unprecedented growth, but manufacturers face increasing challenges around ingredient availability, sustainability, production costs, and supply chain resilience.
Many of today’s most effective skincare ingredients remain difficult and expensive to manufacture at scale, often relying on resource-intensive processes or supply chains vulnerable to disruption.
Vita Hydrokultur is addressing this challenge through its advanced biotechnology platform, which uses plants as highly efficient biological production systems capable of creating complex, high-value molecules with exceptional consistency.
“Beauty brands are no longer looking only for ingredients that work — they are demanding ingredients that are sustainable, transparent, and future-proof,” said Gary Thorneycroft FCA, Founder and CEO of Vita Hydrokultur Group. “Our technology provides a completely new approach to manufacturing premium bioactive ingredients by combining the power of biotechnology with the efficiency of controlled-environment agriculture.”
Plants as Next-Generation Biomanufacturing Platforms
Unlike traditional ingredient production methods, Vita Hydrokultur uses Nicotiana benthamiana, a fast-growing plant species, as a temporary biological manufacturing platform.
Through a controlled process, plants are instructed to produce specific high-value proteins during their growth cycle. These proteins are then extracted and purified to deliver consistent, high-quality ingredients suitable for demanding cosmetic and wellness applications.
The company’s platform offers several competitive advantages:
- High-performance bioactive ingredients manufactured with pharmaceutical-grade consistency
- Animal-free production without dependence on animal-derived materials
- Non-GMO manufacturing approach through temporary plant expression technology
- Complete traceability from molecular design through final ingredient production
- Lower environmental impact compared with traditional manufacturing approaches
Vita Hydrokultur’s vision is to move beyond conventional agriculture and establish plants as scalable biological factories for the next generation of advanced ingredients.
Strategic Expansion Across the UK and Sweden
The company is developing its research and commercial manufacturing capabilities through a strategic expansion plan.
Vita Hydrokultur’s research and development activities are planned at Norwich Research Park, where the company will optimise protein expression systems and validate production protocols before commercial deployment.
For large-scale manufacturing, the company is progressing plans for a commercial production facility in Sweden, leveraging access to renewable energy infrastructure, favourable operating conditions, and efficient development pathways.
The Swedish facility will support Vita Hydrokultur’s ambition to create a scalable manufacturing network capable of supplying global beauty, wellness, and life science companies.
Strong Commercial Potential and Scalable Economics
Early production modelling demonstrates the significant value potential of Vita Hydrokultur’s technology platform.
The company’s projected Phase 1 production metrics include:
- Revenue potential of £638,000 per growth tower
- Gross margins approaching 88%
- Premium ingredient pricing opportunities within high-value markets
- Pathway toward EBITDA profitability by 2029
- Projected revenue growth from approximately £60,000 in 2026 to £8.58 million as commercial capacity expands
The Series A investment will accelerate technology validation, facility development, initial production deployment, and strategic partnerships with global ingredient suppliers and formulation companies.
Experienced Leadership Driving Commercialisation
Vita Hydrokultur is led by an experienced team combining biotechnology expertise, controlled-environment agriculture knowledge, and commercial scaling capability.
Founder and CEO Gary Thorneycroft FCA brings more than two decades of experience supporting and scaling privately owned businesses. He previously co-founded Jones Food Company, one of Europe’s leading vertical farming businesses, where he helped develop large-scale controlled-environment agriculture operations.
He is joined by Dr. Paul Challinor, a recognised specialist in Totally Controlled Environment Horticulture (TCEH), with extensive experience designing and operating advanced agricultural infrastructure.
Together, the leadership team combines financial expertise, scientific innovation, and operational execution to deliver Vita Hydrokultur’s commercial vision.
Investment Opportunity in a Rapidly Evolving Market
The Series A round is being supported by Abell Limited, an ICAEW-authorised chartered accountancy and advisory firm based in Canary Wharf, London, which has assisted Vita Hydrokultur with investment readiness, fundraising strategy, and capital planning.
Chris Valentine, Head of Private Equity at Abell Limited, commented:
“Vita Hydrokultur represents the type of innovative company needed to address major challenges across global ingredient supply chains. The combination of proprietary technology, experienced leadership, and a clear commercial pathway creates a compelling opportunity in a rapidly expanding market.”
The company’s current growth strategy aims to establish Vita Hydrokultur as a leading global supplier of sustainable, high-performance bioactive ingredients, with a long-term objective of significantly expanding production capacity and market reach.
About Vita Hydrokultur Group Ltd
Vita Hydrokultur Group Ltd is a biotechnology manufacturing company specialising in plant-based production of premium recombinant proteins and botanical bioactive ingredients.
Using advanced plant molecular farming and controlled-environment agriculture technologies, Vita Hydrokultur enables beauty, wellness, and life science companies to access sustainable, scalable alternatives to traditional ingredient manufacturing.
The company is developing the future of ingredient production — combining biotechnology, sustainability, and precision manufacturing to deliver next-generation solutions for global markets.
Media Contact:
Vita Hydrokultur Group Ltd